Relationship among three common hematological premalignant conditions
Leukemia
.
2023 Aug;37(8):1719-1722.
doi: 10.1038/s41375-023-01914-z.
Epub 2023 May 5.
Authors
Nicholas J Boddicker
1
,
Sameer A Parikh
2
,
Aaron D Norman
3
,
Kari G Rabe
4
,
Rosalie Griffin
1
,
Timothy G Call
2
,
Dennis P Robinson
4
,
Janet E Olson
3
,
Angela Dispenzieri
2
,
Vincent Rajkumar
2
,
Shaji Kumar
2
,
Neil E Kay
2
5
,
Curtis A Hanson
6
,
James R Cerhan
3
,
David Murray
6
,
Esteban Braggio
7
,
Tait D Shanafelt
8
,
Celine M Vachon
#
9
,
Susan L Slager
#
10
11
Affiliations
1
Division of Computational Biology, Mayo Clinic, Rochester, MN, USA.
2
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
3
Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
4
Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
5
Department of Immunology, Mayo Clinic, Rochester, MN, USA.
6
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
7
Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
8
Department of Medicine, Division of Hematology, Stanford University, Stanford, CA, USA.
9
Division of Epidemiology, Mayo Clinic, Rochester, MN, USA. Vachon.Celine@mayo.edu.
10
Division of Computational Biology, Mayo Clinic, Rochester, MN, USA. Slager.Susan@mayo.edu.
11
Division of Hematology, Mayo Clinic, Rochester, MN, USA. Slager.Susan@mayo.edu.
#
Contributed equally.
PMID:
37147423
PMCID:
PMC10400408
DOI:
10.1038/s41375-023-01914-z
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Hematologic Diseases*
Humans
Precancerous Conditions* / pathology
Grants and funding
R01 CA235026/CA/NCI NIH HHS/United States
P50 CA186781/CA/NCI NIH HHS/United States
P30 CA015083/CA/NCI NIH HHS/United States
U01 CA271014/CA/NCI NIH HHS/United States
R01 AG058266/AG/NIA NIH HHS/United States